Allo by GenieAI Goes Live for All Clients Following Successful Singapore Launch 
Archipelago Video Summit Showcases How the Region is Reinventing for Significant Growth 
TransNusa Celebrates Historical Milestone as it Starts Operating 17 Scheduled Flights Weekly for tts Perth-Bali Route 
Think Business, Think Hong Kong in Milan in November 
Lowe Law Group Celebrates Latest Expansion to 25 US States, Explains Integration of Top Non-Legal Professionals Into Client Service Model Selecta Biosciences to Participate at the Raymond James Human Health Innovation Conference
WATERTOWN, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
Jounce Therapeutics to Host Virtual R&D Day on June 23, 2021
CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage…
PharmaTher To Present At The H.C. Wainwright Psychedelics In Psychiatry And Beyond Virtual Conference
TORONTO, June 16, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB:…
Apexigen and the Nordic Society of Gynaecological Oncology – Clinical Trial Unit Announce Collaborative Phase 2 Study of Sotigalimab (APX005M) in Combination Therapy for Ovarian Cancer
-Study to be conducted at multiple sites across Europe through European Network of Gynaecological Oncological Trial…
Enlivex Annouces Participation in A.G.P.’s Upcoming 2021 Virtual Summer Healthcare Symposium
Nes Ziona, Israel, June 16, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the…
Impel NeuroPharma to Present at the Raymond James Human Health Innovation Conference
SEATTLE, June 16, 2021 (GLOBE NEWSWIRE) — Impel NeuroPharma, a late-stage biopharmaceutical company focused on…
BeyondSpring Announces First Quarter 2021 Financial Results and Provides a Corporate Update
– NDA Filed by U.S. Food and Drug Administration (FDA) and given Priority Review for…
89bio to Participate in Upcoming Investor Conferences
SAN FRANCISCO, June 16, 2021 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical…
Motus GI Announces First Patients Enrolled in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients With a History of Poor Bowel Preparation
FORT LAUDERDALE, Fla., June 16, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
Aprea Therapeutics Announces Phase 1/2 Trial of Eprenetapopt + Venetoclax + Azacitidine in TP53 Mutant AML Meets Complete Remission Primary Efficacy Endpoint
37% CR rate in 30 efficacy-evaluable patients BOSTON, June 16, 2021 (GLOBE NEWSWIRE) — Aprea…
Adagene Announces Inclusion in FTSE Russell Indexes
SAN FRANCISCO and SUZHOU, China, June 16, 2021 (GLOBE NEWSWIRE) — Adagene Inc. (“Adagene”) (Nasdaq:…
Mydecine Unveils Artificial Intelligence Drug Discovery Program
Expanded A.I. and machine learning capabilities will accelerate Mydecine’s broader research and development efforts DENVER,…
Plus Therapeutics Announces DSMB Approval to Proceed into Eighth Cohort in ReSPECT™ Glioblastoma Trial
AUSTIN, Texas, June 16, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Paratek Pharmaceuticals Announces Initiation of Phase 2b Study in Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus Complex (MABc) with NUZYRA® (omadacycline)
— U.S.-Based Sites Ready to Begin Enrolling Patients, Placebo-Controlled Study Evaluating NUZYRA Efficacy at 12…
MacroGenics and Zai Lab Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology
Zai Lab granted combination of regional Asian and global rights for up to four CD3-…
Ocugen Inc. Set to Join Russell 3000® Index
MALVERN, Pa., June 16, 2021 (GLOBE NEWSWIRE) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company…
NetCann Announces Partnership with Leading LatAm Pharma Company, Megalabs
Agreement with Megalabs Strengthens NetCann’s Position as Leading GMP-Certified Medical Cannabis Producer in Latin America…
Affimed Announces Appointment of Uta Kemmerich-Keil to its Supervisory Board
HEIDELBERG, Germany, June 16, 2021 (GLOBE NEWSWIRE) — Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology…
Sigilon Therapeutics Appoints Brooke Story, M.B.A., to its Board of Directors
CAMBRIDGE, Mass., June 16, 2021 (GLOBE NEWSWIRE) — Sigilon Therapeutics, Inc. (NASDAQ:SGTX), a biotechnology company…
Showhomes in Ambleton Set to Open Their Doors June 19, 2021
CALGARY, Alberta, June 16, 2021 (GLOBE NEWSWIRE) — Showhomes in the North West Calgary Community…